Based on Phase 2 trial data (Jastreboff et al., NEJM , 2023), the most commonly reported adverse effects of retatrutide include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (most frequent, particularly during dose escalation) Injection site reactions: Redness, bruising, or mild discomfort Decreased appetite: Generally considered a therapeutic effect but can contribute to nutritional deficiency if severe Increased heart rate: Observed with glucagon receptor agonism
At Chemist Click, GLP-1 tablets start from 88.99
However, it can be risky to those with certain conditions such as cardiovascular disease or breast cancer, and less effective for those already in the menopausal phase
[6] U.S
Simply adding another substance (e.g
Searches like which semaglutide is better pills or injection reflect this decision-making process